Identification of disease ameliorated metabolite candidates from Gut Microbes and their interacting targets based on a novel estimating function.
Saved in:
| Title: | Identification of disease ameliorated metabolite candidates from Gut Microbes and their interacting targets based on a novel estimating function. |
|---|---|
| Authors: | Cui H; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China., Liao Z; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China., Kuang X; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China., Zhang JY; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China., Song CY; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China., Liu YJ; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China., Cheng Z; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.; Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China., Deng ZX; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China., Guo FB; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China. |
| Source: | Frontiers in microbiology [Front Microbiol] 2026 Mar 10; Vol. 17, pp. 1770840. Date of Electronic Publication: 2026 Mar 10 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41889639 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identification of disease ameliorated metabolite candidates from Gut Microbes and their interacting targets based on a novel estimating function. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cui+H%22">Cui H</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Liao+Z%22">Liao Z</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Kuang+X%22">Kuang X</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Zhang+JY%22">Zhang JY</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Song+CY%22">Song CY</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Liu+YJ%22">Liu YJ</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Cheng+Z%22">Cheng Z</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.; Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Deng+ZX%22">Deng ZX</searchLink>; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Guo+FB%22">Guo FB</searchLink>; Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548977%22">Frontiers in microbiology</searchLink> [Front Microbiol] 2026 Mar 10; Vol. 17, pp. 1770840. <i>Date of Electronic Publication: </i>2026 Mar 10 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548977 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-302X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221664302X%22">1664302X </searchLink><i>NLM ISO Abbreviation: </i>Front Microbiol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41889639 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fmicb.2026.1770840 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1770840 Titles: – TitleFull: Identification of disease ameliorated metabolite candidates from Gut Microbes and their interacting targets based on a novel estimating function. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cui H – PersonEntity: Name: NameFull: Liao Z – PersonEntity: Name: NameFull: Kuang X – PersonEntity: Name: NameFull: Zhang JY – PersonEntity: Name: NameFull: Song CY – PersonEntity: Name: NameFull: Liu YJ – PersonEntity: Name: NameFull: Cheng Z – PersonEntity: Name: NameFull: Deng ZX – PersonEntity: Name: NameFull: Guo FB IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 03 Text: 2026 Mar 10 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1664-302X Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in microbiology Type: main |
| ResultId | 1 |